D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 45 Citations 6,590 132 World Ranking 3957 National Ranking 29

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Neuroscience
  • Dopamine

Neuroscience, Endocrinology, Internal medicine, Dopamine and Cannabinoid are his primary areas of study. Jussi Hirvonen combines subjects such as Carfentanil and Endogenous opioid with his study of Neuroscience. His Endocrinology research focuses on subjects like Receptor, which are linked to Major depressive disorder.

His Internal medicine research incorporates themes from White matter, Fractional anisotropy and Voxel. His primary area of study in Dopamine is in the field of Dopamine receptor D2. His research in Cannabinoid intersects with topics in Radioligand, Abstinence, Cannabinoid receptor, Pharmacology and Cannabis.

His most cited work include:

  • Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers (349 citations)
  • Is emotional contagion special? An fMRI study on neural systems for affective and cognitive empathy. (238 citations)
  • Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. (141 citations)

What are the main themes of his work throughout his whole career to date?

Jussi Hirvonen focuses on Internal medicine, Endocrinology, Neuroscience, Positron emission tomography and Receptor. He focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Anxiety and, in certain cases, Mood and Depression. His Endocrinology research is multidisciplinary, relying on both Serotonin transporter and Carfentanil.

His research in Neuroscience focuses on subjects like Endogenous opioid, which are connected to Physical exercise and Opioidergic. His work is dedicated to discovering how Positron emission tomography, Artificial intelligence are connected with Neuroinformatics and other disciplines. Jussi Hirvonen has included themes like Psychosis and Addiction in his Dopamine study.

He most often published in these fields:

  • Internal medicine (42.41%)
  • Endocrinology (38.61%)
  • Neuroscience (29.11%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (42.41%)
  • Endocrinology (38.61%)
  • Amygdala (13.92%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Endocrinology, Amygdala, Carfentanil and Positron emission tomography. His studies in Internal medicine integrate themes in fields like Major depressive disorder, Depression and Anxiety. Jussi Hirvonen interconnects Endogenous opioid and Fatty acid in the investigation of issues within Endocrinology.

The study incorporates disciplines such as Brain activity and meditation and Functional magnetic resonance imaging in addition to Amygdala. His work in Carfentanil tackles topics such as μ-opioid receptor which are related to areas like Radioligand and -Naloxone. In his study, Raclopride and Binding potential is strongly linked to Pattern recognition, which falls under the umbrella field of Positron emission tomography.

Between 2018 and 2021, his most popular works were:

  • Interindividual variability and lateralization of μ-opioid receptors in the human brain (10 citations)
  • Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety (9 citations)
  • Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety (9 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Neuroscience

Jussi Hirvonen mainly investigates Pattern recognition, Reference Region, Image processing, Neuroinformatics and Artificial intelligence. His Pattern recognition research includes themes of Raclopride and Control subjects. His Control subjects study frequently draws connections between adjacent fields such as Positron emission tomography.

His work deals with themes such as Body mass index, Obesity, Weight loss, Leptin and Beta oxidation, which intersect with Positron emission tomography. He combines topics linked to Binding potential with his work on Reference Region.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

Hirvonen J;Goodwin Rs;Li Ct;Terry Ge.
Molecular Psychiatry (2012)

559 Citations

Is emotional contagion special? An fMRI study on neural systems for affective and cognitive empathy.

Lauri Nummenmaa;Jussi Hirvonen;Riitta Parkkola;Jari K. Hietanen.
NeuroImage (2008)

444 Citations

Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity.

Lauri Nummenmaa;Jussi Hirvonen;Jarna C. Hannukainen;Heidi Immonen.
PLOS ONE (2012)

250 Citations

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

Jussi Hirvonen;Theo G. M. van Erp;Jukka Huttunen;Sargo Aalto.
Archives of General Psychiatry (2005)

202 Citations

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

Jussi Hirvonen;Hasse Karlsson;Hasse Karlsson;Jaana Kajander;Antti Lepola.
The International Journal of Neuropsychopharmacology (2008)

189 Citations

Increased Brain Fatty Acid Uptake in Metabolic Syndrome

Anna Karmi;Patricia Iozzo;Antti Viljanen;Jussi Hirvonen.
Diabetes (2010)

180 Citations

Social Laughter Triggers Endogenous Opioid Release in Humans

Sandra Manninen;Lauri Tuominen;Robin I. Dunbar;Tomi Karjalainen.
The Journal of Neuroscience (2017)

177 Citations

Obesity Is Associated with Decreased μ-Opioid But Unaltered Dopamine D2 Receptor Availability in the Brain

Henry K. Karlsson;Lauri Tuominen;Jetro J. Tuulari;Jussi Hirvonen.
The Journal of Neuroscience (2015)

176 Citations

Impact of Prolonged Cannabinoid Excretion in Chronic Daily Cannabis Smokers' Blood on Per Se Drugged Driving Laws

Mateus M. Bergamaschi;Erin L. Karschner;Robert S. Goodwin;Karl B. Scheidweiler.
Clinical Chemistry (2013)

152 Citations

Social touch modulates endogenous μ-opioid system activity in humans.

Lauri Nummenmaa;Lauri Tuominen;Robin Dunbar;Jussi Hirvonen.
NeuroImage (2016)

149 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jussi Hirvonen

Christer Halldin

Christer Halldin

Karolinska Institutet

Publications: 61

Lauri Nummenmaa

Lauri Nummenmaa

Turku University Hospital

Publications: 58

Oliver D. Howes

Oliver D. Howes

King's College London

Publications: 53

Lars Farde

Lars Farde

Karolinska Institute

Publications: 44

Pirjo Nuutila

Pirjo Nuutila

Turku University Hospital

Publications: 39

Nora D. Volkow

Nora D. Volkow

National Institutes of Health

Publications: 38

Jarmo Hietala

Jarmo Hietala

Turku University Hospital

Publications: 34

Marilyn A. Huestis

Marilyn A. Huestis

National Institute on Drug Abuse

Publications: 31

Annette Horstmann

Annette Horstmann

University of Helsinki

Publications: 29

J. John Mann

J. John Mann

Columbia University

Publications: 27

Robin I. M. Dunbar

Robin I. M. Dunbar

University of Oxford

Publications: 27

Robert B. Innis

Robert B. Innis

National Institutes of Health

Publications: 26

Siegfried Kasper

Siegfried Kasper

Medical University of Vienna

Publications: 25

Wayne C. Drevets

Wayne C. Drevets

Johnson & Johnson (United States)

Publications: 25

Anissa Abi-Dargham

Anissa Abi-Dargham

Stony Brook University

Publications: 25

Andrea Varrone

Andrea Varrone

Karolinska Institute

Publications: 24

Trending Scientists

Steven Ongena

Steven Ongena

University of Zurich

Barry G. Evans

Barry G. Evans

University of Surrey

Xiao-Qing Yang

Xiao-Qing Yang

Brookhaven National Laboratory

Hiromu Sakurai

Hiromu Sakurai

Kyoto Pharmaceutical University

Jian Lu

Jian Lu

Chinese Academy of Sciences

Jeremy K. M. Sanders

Jeremy K. M. Sanders

University of Cambridge

Han-Ki Kim

Han-Ki Kim

Sungkyunkwan University

Adriano Nunes-Nesi

Adriano Nunes-Nesi

Universidade Federal de Viçosa

Ashok K. Singh

Ashok K. Singh

Indian Agricultural Research Institute

Carsten Janke

Carsten Janke

University of Paris-Saclay

Gavin R. Screaton

Gavin R. Screaton

University of Oxford

Richard I. Carp

Richard I. Carp

New York State Office for People With Developmental Disabilities

Marina Frontasyeva

Marina Frontasyeva

Joint Institute for Nuclear Research

Konstantinos I. Stergiou

Konstantinos I. Stergiou

Aristotle University of Thessaloniki

Cynthia L. Darlington

Cynthia L. Darlington

University of Otago

Jone L. Pearce

Jone L. Pearce

University of California, Irvine

Something went wrong. Please try again later.